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Vagus-macrophage-hepatocyte link promotes
post-injury liver regeneration and whole-body
survival through hepatic FoxM1 activation
Tomohito Izumi1, Junta Imai1,2, Junpei Yamamoto1, Yohei Kawana1, Akira Endo1, Hiroto Sugawara1,
Masato Kohata1, Yoichiro Asai1, Kei Takahashi1, Shinjiro Kodama1, Keizo Kaneko1, Junhong Gao1, Kenji Uno1,
Shojiro Sawada1, Vladimir V. Kalinichenko3, Yasushi Ishigaki1,5, Tetsuya Yamada1 & Hideki Katagiri1,4
The liver possesses a high regenerative capacity. Liver regeneration is a compensatory
response overcoming disturbances of whole-body homeostasis provoked by organ defects.
Here we show that a vagus-macrophage-hepatocyte link regulates acute liver regeneration
after liver injury and that this system is critical for promoting survival. Hepatic Foxm1 is rapidly
upregulated after partial hepatectomy (PHx). Hepatic branch vagotomy (HV) suppresses this
upregulation and hepatocyte proliferation, thereby increasing mortality. In addition, hepatic
FoxM1 supplementation in vagotomized mice reverses the suppression of liver regeneration
and blocks the increase in post-PHx mortality. Hepatic macrophage depletion suppresses
both post-PHx Foxm1 upregulation and remnant liver regeneration, and increases mortality.
Hepatic Il-6 rises rapidly after PHx and this is suppressed by HV, muscarinic blockade or
resident macrophage depletion. Furthermore, IL-6 neutralization suppresses post-PHx Foxm1
upregulation and remnant liver regeneration. Collectively, vagal signal-mediated IL-6 pro-
duction in hepatic macrophages upregulates hepatocyte FoxM1, leading to liver regeneration
and assures survival.
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The liver possesses an enormous capacity for regeneration.After the loss of hepatic tissue caused by toxins or partialsurgical removal, remnant hepatocytes markedly pro-
liferate to restore the liver’s original mass and functions1. This
process is a compensatory response overcoming the disturbance
of whole-body homeostasis provoked by the functional organ
defect. Thus, uncovering the precise mechanism of this regen-
erative response would lead to better understanding of the whole-
body homeostatic system.
While the roles of humoral factors, including cytokines and
growth factors, in liver regeneration have been extensively
investigated2, several studies have also suggested a role of vagal
nerve signals in liver regeneration3–5. After partial hepatectomy
(PHx), the liver predominantly regenerates through the pro-
liferation of pre-existing hepatocytes6. Hepatocyte proliferation
after PHx reportedly begins at 12–16 h and peaks between 36 and
48 h postoperatively in rodents7. Reﬂecting this rapid hepatocyte
response, the weight of the remnant liver doubles and has been
restored to ~60–70% of the original weight within the ﬁrst 72 h
after 70% PHx, with eventual restoration of the original weight by
14 days after the operation8,9. These ﬁndings suggest that the liver
regenerative process after injury is mechanistically divided into at
least two phases, i.e., an early phase characterized by rapid
regeneration and a late phase in which the ﬁnal organ size is
determined. In particular, rapid regeneration after severe organ
injury leads to prompt functional recovery which is critical for
maintaining homeostasis. Hepatic branch vagotomy reportedly
suppresses post PHx liver regeneration, especially in the early
phase of regeneration3,4. However, the mechanisms by which
vagal nerve signals induce rapid hepatocyte proliferation after
injury remain largely unknown.
Herein, using PHx as an acute organ defect model, we inves-
tigated the molecular mechanism underlying acute liver regen-
eration. Experiments employing blockade of the hepatic branch of
the vagus, inducible hepatocyte-speciﬁc FoxM1 deﬁciency and
adenoviral supplementation of hepatic FoxM1 revealed vagal
signals to be involved in rapid activation of the hepatocyte FoxM1
pathway, leading to prompt hepatocyte proliferation after PHx.
Importantly, while hepatic branch vagotomy increased post-
operative mortality, hepatic supplementation of FoxM1 blocked
the increase in mortality, indicating the unraveled mechanism to
be critical for promoting survival after liver injury. It is note-
worthy that macrophages serve as intermediaries for vagal signals
and acute activation of the hepatocyte FoxM1 pathway. Acet-
ylcholine, secreted from the vagus, and interleukin (IL)-6, from
macrophages, are involved in the molecular mechanism of the
vagal nerve–macrophage–hepatocyte transduction. We recently
reported vagal signals to directly activate the FoxM1 pathway in
pancreatic β-cells, thereby promoting compensatory
proliferation10,11. In contrast to richly innervated pancreatic
islets12,13, vagal nerves in the liver were very scarce and were
observed only around the portal region14. Thus, this elaborate
multistep mechanism, consisting of neuronal, immune, and
parenchymal cells, may allow urgent regenerative signals to be
ampliﬁed and spread throughout the entire organ, thereby pro-
moting prompt liver regeneration and assuring whole-body sur-
vival after severe liver injury.
Results
Vagal signals are critical for post PHx survival. First, we per-
formed 70% PHx concomitantly with hepatic branch vagotomy
(HV) (PHx-HV) or sham operation for HV (PHx-sham) in mice,
followed by analyzing the survival rates. Notably, the post-
operative mortality of PHx-HV mice, within 3 days after surgery,
was markedly higher than that in PHx-sham mice or non-
hepatectomized mice subjected to HV alone (HV alone) (Fig. 1a).
Histological analysis immediately after their deaths showed that,
in contrast to PHx-sham mice, focally necrotic areas with marked
bleeding were diffusely located in the livers of PHx-HV mice
(Supplementary Fig. 1a). In contrast, regardless of whether or not
they had undergone HV, none of the mice, which had survived
the initial 3 postoperative days, died during the period of 14 days
after the operation (Fig. 1a). In surviving animals, recovery of the
hepatic weights of PHx-HV mice was signiﬁcantly suppressed, as
compared with those of PHx-sham mice on day 3 (Supplemen-
tary Fig. 1b). Until day 5, the weights of livers from both PHx-
sham- and PHx-HV mice were remarkably increased, with an
edematous appearance (Supplementary Fig. 1c), and hepatic
weights in PHx-HV mice had almost caught up with those in
PHx-sham mice on day 7 (Supplementary Fig. 1b). Thus, vagal
signals are essential for assuring survival after PHx.
BrdU-positive hepatocytes in PHx-sham mice were remarkably
increased as compared with those in mice that had received
the sham operation for PHx, by ~30-fold, on day 2 after PHx.
In contrast, HV markedly suppressed the increases in BrdU-
positive proliferating hepatocytes (Fig. 1b, c). Similar results were
obtained when HV was performed 10 days prior to PHx
(Supplementary Fig. 1d). Consistent with hepatic weight changes
after PHx, the difference in BrdU-positive hepatocyte ratios
between PHx-sham- and PHx-HV mice lost signiﬁcance on days
5 and 7 (Fig. 1b, c). There were no signiﬁcant differences in body
weights or food intakes, during the entire 14-day observation
periods after PHx, between surviving PHx-sham mice and PHx-
HV mice (Supplementary Fig. 1e, f), indicating that neither HV-
induced increments in post-injury mortality nor suppression of
the liver regenerative response was attributable mainly to general
conditions, including nutritional states. These ﬁndings suggest
that vagal signals play important roles in acute-phase liver
regeneration, which appears to be critical for the post PHx
survival.
Vagal signals are involved in activation of hepatic FoxM1 after
PHx. We next investigated the molecular mechanism underlying
the vagal signal-mediated acute liver regeneration after PHx. We
recently reported that vagal signals promote pancreatic β-cell
proliferation via an intracellular FoxM1-dependent mechanism11.
FoxM1 affects several aspects of cell cycle progression15, such as
promoting the G1/S transition by triggering the transcriptions of
several cyclins, including cyclin A2 (Ccna2)16–18, regulation of the
G2/M transition by transactivating cyclin-dependent kinase 1
(Cdk1)17,19, and control of proper progression of mitosis by
increasing the expressions of several mitogenic genes, such as
polo-like kinase 1 (Plk1)20. Therefore, we explored whether
FoxM1 expression in hepatocytes is involved in vagal signal-
mediated cellular proliferation. PHx markedly upregulated Foxm1
and cell cycle-related genes downstream from FoxM1, such as
Cdk1, Ccna2, and Plk1, as well as a cell proliferation marker,
Mki67, by several dozen to 100-fold on postoperative days 2 and 3
(Fig. 2a and Supplementary Fig. 1g). Importantly, PHx-induced
upregulations of FoxM1 and its related genes were almost com-
pletely blocked by HV (Fig. 2a and Supplementary Fig. 1g).
Consistently, immunoblotting revealed that expressions of
hepatic FoxM1 and its downstream proteins, such as Cyclin A2,
Cdk1, and PLK1, were markedly increased on postoperative day 2
and that these increases were blocked by HV (Fig. 2b). Thus,
vagal signals are essential for activation of the hepatic FoxM1
pathway in the early phase after PHx, leading to acute hepatocyte
replication. Again, in contrast to the early postoperative periods,
HV had much weaker and minimal, respectively, impacts on
PHx-induced upregulations of FoxM1-related gene expressions
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on days 5 and 7 (Supplementary Fig. 1h, i), although the mag-
nitudes of increases differed due to using different detection
procedures. Thus, hepatocyte regeneration in the late phase is
unlikely to be mediated by vagal signals.
FoxM1 activation promotes liver regeneration and survival. To
explore whether the FoxM1 upregulation observed in the early
phase after PHx is actually responsible for post PHx liver
regeneration, we generated tamoxifen-inducible liver-speciﬁc
FoxM1 knockout mice (iFoxM1LKO mice) by crossing serum
albumin promoter-CreER mice21 and FoxM1-ﬂoxed mice22. In
contrast to congenital liver-speciﬁc FoxM1 knockout mice22,
iFoxM1LKO mice are not deﬁcient in hepatocyte FoxM1 during
developmental and growth stages. Tamoxifen administration to
these mice markedly decreased Foxm1 expressions in the liver, by
71% (Supplementary Fig. 2). As expected, PHx-induced upregu-
lations of the cell cycle-related genes (Fig. 3a) and increases in
BrdU-positive hepatocytes (Fig. 3b) on day 2 after the surgeries
were markedly blunted in iFoxM1LKO mice, showing that
FoxM1 expressed in hepatocytes is essential for accelerating the
hepatocyte cell cycle, thereby promoting hepatocyte replication in
the early phase after PHx.
Next, to explore the role of FoxM1 in vagal signal-mediated
liver regeneration, we examined the effects of HV on liver
regeneration after PHx using mice, in which hepatic FoxM1 had
been supplemented by adenoviral gene transduction. We used
adenovirus containing the human Foxm1 gene to distinguish
endogenous FoxM1 from exogenously expressed FoxM1. We
selected an adenoviral titer at which gene transduction increased
exogenous Foxm1 expression in the livers of mice to levels similar
to those of hepatic endogenous FoxM1 in PHx-sham mice
induced on day 2 after PHx (Supplementary Fig. 3a). Strikingly,
in hepatically FoxM1-supplemented mice, HV failed to suppress
PHx-induced increments in expressions of the genes downstream
from FoxM1 (Fig. 3c). This effect was also observed in BrdU-
positive hepatocytes (Fig. 3d). Notably, hepatic FoxM1 supple-
mentation completely blocked increases in mortality after PHx
in vagotomized mice (Fig. 3e). Interestingly, exogenous (human)
FoxM1 expression in normal mice, without PHx or HV, did
not alter the expressions of either endogenous mouse FoxM1
or its target genes, nor that of Mki67 (Supplementary Fig. 3b).
Furthermore, hepatic FoxM1 overexpression in PHx-sham
mice did not yield further enhancements of hepatocyte
proliferative responses, suggesting that the hepatic FoxM1
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Fig. 1 Vagal signals are critical for post PHx survival. a Cumulative survival of mice that underwent PHx-sham (n= 26), PHx-HV (n= 26), and HV alone
(n= 18). b Representative images of liver sections immunostained for BrdU on days 2, 5, and 7 after sham operation for PHx (SO), PHx-sham, or PHx-HV.
Scale bars indicate 100 µm. c BrdU-positive hepatocyte ratios in SO mice (n= 5–6 per group), PHx-sham mice (n= 4–6 per group), and PHx-HV
mice (n= 4–6 per group) on postoperative days 2, 5, and 7. The magniﬁed graphs on days 5 and 7 are shown in framed boxes with lowered scale ranges.
*P < 0.05; **P < 0.01 assessed by log-rank test with Bonferroni correction (a) or one-way ANOVA followed by Bonferroni’s post hoc test (c). n.s., not
signiﬁcant
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pathway had already been fully activated in response to PHx
(Supplementary Fig. 3c, d). In addition, administration of carba-
chol to normal mice failed to upregulate hepatic FoxM1-
related genes (Supplementary Fig. 3e). These results indicate
that, under early-phase post-PHx conditions, activation of the
hepatic FoxM1 pathway mediates vagal signal-induced promo-
tion of hepatocyte replication and the resultant whole-
body survival.
Macrophages mediate vagus-induced hepatic FoxM1 activation.
Our next goal was to elucidate the mechanism by which vagal
signals activate the FoxM1 pathway in hepatocytes. First, to
examine whether the muscarinic receptor signaling induced by
acetylcholine, the main neurotransmitter released by the vagal
nerve, is involved, mice were treated with atropine, a muscarinic
receptor antagonist, followed by PHx. With atropine treatment,
the increases in BrdU-positive hepatocytes were markedly
reduced (Fig. 4a) and recovery of hepatic weights in the early
phase after PHx was suppressed (Fig. 4b). Consistently, upregu-
lations of hepatic Foxm1 and its target genes, as well as Mki67
after PHx were signiﬁcantly blocked by atropine treatment
(Fig. 4c). These data indicate that muscarinic signals are involved
in promoting acute liver regenerative responses after PHx.
We then attempted to elucidate the molecular mechanism
underlying vagal signal-mediated hepatocyte proliferation in vitro
by using a murine hepatoma cell line, Hepa1–6 cells. Unexpect-
edly, however, direct stimulation with carbachol, a cholinergic
receptor agonist, did not upregulate Foxm1 and Mki67 gene
expressions in the cultured hepatocytes (Supplementary Fig. 4a).
Therefore, we examined the possibility that an indirect mechan-
ism(s) mediates the effects of vagal signals on hepatocyte
proliferation. Since resident macrophages are reportedly involved
in tissue repair in several tissues23, we examined post PHx
hepatocyte proliferation using mice in which hepatic macro-
phages had been depleted by treatment with clodronate
liposomes. Clodronate liposome administration signiﬁcantly
decreased hepatic expressions of macrophage markers (Fig. 5a),
indicating successful depletion of hepatic macrophages. Intrigu-
ingly, clodronate liposome administration markedly blunted
activation of the FoxM1 pathway in the liver on day 2 after
PHx, as compared with control liposome treatment (Fig. 5b). In
addition, the increases in BrdU-positive hepatocytes after PHx
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were markedly inhibited by clodronate liposome administration
(Fig. 5c). Of note, HV failed to exert further inhibitory effects on
the acute hepatocyte proliferation responses of clodronate
liposome-treated mice (Fig. 5b, c). Furthermore, adenoviral
supplementation of hepatic FoxM1 signiﬁcantly blunted the
inhibitory effects of macrophage depletion on acute hepatocyte
proliferation responses after PHx (Fig. 5d, e). Notably, the post-
PHx mortality of macrophage-depleted mice, within 2 days
postoperatively, was markedly higher than those of mice without
macrophage depletion (Fig. 5f), observations similar to those in
mice undergoing HV (Fig. 1a). These ﬁndings, taken together,
suggest that hepatic macrophages contribute to mediating vagal
signals to hepatocytes, thereby activating the hepatocyte FoxM1
pathway and promoting hepatocyte proliferation.
Vagal signals increase macrophage IL-6 production after PHx.
What then is the mediator of the macrophage–hepatocyte link?
Activated macrophages are well-known to produce and release
pro-inﬂammatory cytokines, including IL-624, and the cellular
source of IL-6 after PHx was reported to be resident macro-
phages25. Therefore, we focused on IL-6 production after PHx. Il-
6 expression in the remnant liver of PHx-sham mice was mark-
edly increased at 6 h after PHx and, importantly, this Il-6 upre-
gulation was almost completely abolished by HV (Fig. 6a). Plasma
IL-6 concentrations were also increased after PHx, and these
increases were suppressed by vagotomy (Supplementary Fig. 4b).
In addition, upregulation of Il-6 by PHx was completely absent in
clodronate liposome-treated mice (Fig. 4b). Consistent with the
results of hepatocyte proliferative responses (Fig. 5b, c), HV failed
to exert further inhibitory effects on upregulation of Il-6 in clo-
dronate liposome-treated mice (Fig. 6b). Therefore, these ﬁndings
indicate that, after PHx, vagal signals enhance IL-6 production by
hepatic macrophages in the remnant liver.
We next investigated the effects of cholinergic signals on
macrophage IL-6 production employing ex vivo experiments
using primary macrophages isolated from the peritoneal cavity
after intraperitoneal thioglycollate administration. Strikingly,
carbachol treatment markedly increased Il-6 expression in these
primary macrophages in a dose-dependent manner (Supplemen-
tary Fig. 4c), and this increase was signiﬁcantly blunted by co-
treatment with atropine (Fig. 6c). In contrast, carbachol treatment
of primary hepatocytes failed to increase Il-6 expression
(Supplementary Fig. 4d). Moreover, in vivo atropine treatment
signiﬁcantly suppressed PHx-induced increases in Il-6 expression
in the liver (Fig. 6d). Collectively, vagus-derived cholinergic
signals can directly upregulate macrophage IL-6 production
through a muscarinic receptor-dependent mechanism.
IL-6 mediates vagal signal-induced hepatic FoxM1 activation.
To examine whether IL-6 activates the FoxM1 pathway in
hepatocytes, we treated primary hepatocytes with IL-6. Baseline
Foxm1 levels in primary hepatocytes were approximately eight-
fold higher than those in non-treated quiescent livers (Supple-
mentary Fig. 5a). The isolation procedure may intrinsically
enhance Foxm1 expression. Even under these conditions, IL-6
treatment of primary hepatocytes further increased expressions of
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Foxm1, its target genes, and Mki67 (Fig. 7a). It should be noted
that IL-6-induced upregulations of these cell cycle-related genes
were markedly blocked in primary hepatocytes from iFoxM1LKO
mice (Fig. 7a). These ﬁndings indicate that IL-6 accelerates cell
cycling of hepatocytes through a FoxM1-dependent mechanism.
IL-6 is well-known to exert its effects through signal transducer
and activator of transcription 3 (STAT3) signaling26. IL-6
promotes phosphorylation and homodimerization of STAT3,
thereby increasing STAT3 translocation to the nucleus, leading to
transactivation of its target genes26. Since STAT3 reportedly
transactivates Foxm1 gene expression27, we next examined
hepatic STAT3 phosphorylation of PHx-sham- and PHx-HV
mice. Compared with control mice, hepatic STAT3 phosphoryla-
tion was signiﬁcantly increased at 24 h after PHx, and this
enhancement of phosphorylation was blunted by HV (Fig. 7b).
Next, we pretreated primary hepatocytes with STAT3 inhibitor
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peptide, which inhibits both homodimerization of STAT3 and
heterodimerization of STAT3 and STAT128, followed by treat-
ment with IL-6. Pretreatment with the STAT3 inhibitor blocked
IL-6-mediated increases in FoxM1 and its target genes as well as
Mki67 (Supplementary Fig. 5b). In addition, we examined the
phosphorylation of STAT1 as well as that of STAT5 after PHx. In
contrast to STAT3, phosphorylations of STAT1 and STAT5 were
not altered after PHx (Supplementary Fig. 5c). These results
suggest that IL-6 promotes phosphorylation and homodimeriza-
tion of STAT3, thereby upregulating FoxM1-related genes in
hepatocytes.
Finally, to examine the signiﬁcance of IL-6 in activation of the
hepatic STAT3–FoxM1 pathway in vivo, we blocked IL-6
signaling by administering anti-IL-6 antibody, followed by PHx
Fig. 5 Macrophages mediate vagus-induced hepatic FoxM1 activation. a (Upper panels) Representative images of liver sections immunostained for F4/80
from mice 24 h after receiving control and clodronate liposomes. Scale bars indicate 100 µm. (Lower panel) Relative gene expressions of F4/80 in the liver
24 h after control (n= 4) and clodronate (n= 4) liposome administration. b Relative expressions of Foxm1, its target genes, and MKi67 in the liver 2 days
after surgery in SO+ control mice (n= 6), PHx-sham+ control mice (n= 8), PHx-sham+ clodronate mice (n= 6), and PHx-HV+ clodronate mice (n=
6). c (Left panels) Representative images of liver sections immunostained for BrdU on day 2 in SO+ control-, PHx-sham+ control-, PHx-sham+
clordronate-, and PHx-HV+ clodronate mice. Scale bars indicate 100 µm. (Right panel) BrdU-positive hepatocyte ratios in SO+ control mice (n= 6), PHx-
sham+ control mice (n= 8), PHx-sham+ clodronate mice (n= 6,) and PHx-HV+ clodronate mice (n= 6) 2 days after surgery. d Relative expressions of
Foxm1, its target genes, and MKi67 in the liver 2 days after SO in mice receiving control liposome and Ad-LacZ (n= 6) and PHx in mice receiving control
liposome and Ad-LacZ (n= 6), clodronate liposome and Ad-LacZ (n= 6), and clodronate liposome and Ad-hFoxM1 (n= 6). e (Left panels) Representative
images of liver sections immunostained for BrdU on day 2 after SO in mice receiving control liposome and Ad-LacZ and PHx in mice receiving control
liposome and Ad-LacZ, clodronate liposome and Ad-LacZ, and clodronate liposome and Ad-hFoxM1. Scale bars indicate 100 µm. (Right panel) BrdU-
positive hepatocyte ratios in the liver 2 days after SO in mice receiving control liposome and Ad-LacZ (n= 6) and PHx in mice receiving control liposome
and Ad-LacZ (n= 6), clodronate liposome and Ad-LacZ (n= 6), and clodronate liposome and Ad-hFoxM1 (n= 6). f Mortality rates within 2 postoperative
days in PHx+ control mice (n= 15) and PHx+ clodronate mice (n= 15). Data are presented as means ± SEM. *P < 0.05; **P < 0.01 assessed by one-way
ANOVA followed by Bonferroni’s post hoc test (b, c, d, e) or assessed by unpaired t test (a). n.s., not signiﬁcant
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surgery. IL-6 neutralization signiﬁcantly suppressed the hepatic
STAT3 phosphorylation enhanced by PHx (Supplementary
Fig. 5d). Under these conditions, upregulations of Foxm1 and
its target cell cycle-related genes, as well as Mki67 on day 2 after
PHx were markedly suppressed in anti-IL-6 antibody-treated
mice (Fig. 7c). Thus, IL-6 signaling plays key roles in activation of
the FoxM1 pathway in hepatocytes and in the proliferation of
hepatocytes during the acute phases after PHx.
Taken together, our observations suggest that vagal nerve-
derived cholinergic signals are likely to stimulate IL-6 production
by resident macrophages in the liver, and that, in a paracrine
manner, IL-6 enhances hepatocyte proliferation based on a
FoxM1-dependent mechanism (Fig. 8).
Discussion
Using the PHx model, we have clariﬁed that vagal signal-
regulated acute liver regenerative responses are critical for pro-
moting survival after severe liver injury. Postoperative mortality
was high in PHx-HV mice but, regardless of whether or not HV
had been performed, all of the mice which had survived the initial
3 postoperative days survived for at least 14 days after the
operation (Fig. 1a). Thus, acute recovery of liver mass within a
few days after PHx is critical for life maintenance. Increases in
postoperative mortality in PHx-HV mice were accompanied by
areas of focal necrosis with marked bleeding in the livers of these
mice. Further studies are necessary to elucidate the mechanisms
by which HV leads to such pathological changes. Meanwhile,
hepatic FoxM1 supplementation in PHx-HV mice completely
blocked the increases in mortality (Fig. 3e) with recovery of acute
liver regeneration (Fig. 3c, d). On the other hand, adenoviral
FoxM1 expression or carbachol administration to normal mice
had no effects on the FoxM1 pathway (Supplementary Fig. 3b, e).
These ﬁndings suggest that additional and unknown signals,
induced by PHx, are necessary for promoting hepatocyte pro-
liferation. Thus, vagus-mediated activation of the FoxM1 pathway
is critical, especially when prompt hepatocyte regeneration is
required, and functions as a preventive mechanism against whole-
body death after injury. In contrast, chronic liver regeneration
occurred even in PHx-HV mice, indicating different mechanisms
and roles of liver regeneration in the acute versus chronic phases.
Late-phase liver regeneration was proposed to be promoted by
humoral factors including several growth factors7, and could be
important in regulating liver size. On the other hand, neuronal
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signals may be advantageous for inducing prompt compensatory
regeneration, which confers a survival advantage for animals
suffering severe crises such as an organ defect. Recovery of liver
weight within 72 h after PHx is reportedly reduced in 40- as
compared to 4-week-old mice29. It is noteworthy that 40-week-
old mice showed a low survival rate within 72 h after PHx29,
similar to that of PHx-HV mice in the present study. Taken
together with our results, the lower survival rate after PHx
associated with aging might be attributable to impairment of the
mechanism, underlying acute liver regenerative responses, eluci-
dated in the present study.
In this study, we have delineated a full picture of vagal signal-
regulated acute hepatic regenerative responses. We have
unmasked several novel mechanisms involved in this process.
First, vagal nerve signals play critical roles in upregulating the
hepatocyte FoxM1 pathway, thereby promoting rapid liver
regeneration in the early phases after injury. Second, resident
macrophages mediate processes involving vagal signals and
prompt hepatocyte proliferation in these regenerative responses.
Third, IL-6 is a critical mediator in the mechanism linking
macrophages and hepatocytes.
Consistent with the results of a previous study using congenital
FoxM1 knockout mice22, liver-speciﬁc induction of FoxM1 deﬁ-
ciency prior to PHx markedly suppressed liver regeneration in the
early phase after PHx (Fig. 3a, b). Notably, we further showed
that HV did not suppress liver regeneration and whole-body
survival in hepatically FoxM1-supplemented mice (Fig. 3d, e).
Thus, vagal signal-induced FoxM1 upregulation in hepatocytes
is necessary and sufﬁcient for accelerating the hepatocyte cell
cycle, thereby promoting hepatocyte replication in the early phase
after PHx. Given that vagus-mediated FoxM1 activation is
involved in compensatory β-cell proliferation11, the vagus-FoxM1
linking mechanism may be shared by a variety of tissues for
in vivo regeneration.
Direct carbachol stimulation did not upregulate FoxM1-related
genes in hepatocytes (Supplementary Fig. 4a), but did markedly
enhance IL-6 production in macrophages (Fig. 6c), suggesting
the targets of vagal signals to be hepatic macrophages, rather
than hepatocytes. As reported24,30, hepatic macrophage-depleted
mice showed marked impairment of liver regeneration (Fig. 5c).
Importantly, this impairment was accompanied by blunting of
FoxM1 pathway activation (Fig. 5b), and vagotomy failed to exert
further inhibitory effects on either acute liver regenerative
responses (Fig. 5b, c) or the upregulation of hepatic Il-6 (Fig. 6b).
Vagal nerve signals reportedly regulate resident macrophages,
thereby modulating several biological conditions in peripheral
organs, such as inﬂammation31,32 and metabolism33. In this
study, we clariﬁed that the vagal nerve–macrophage link is
further involved in the organ regenerative process. In this process,
the cholinergic signal is identiﬁed as a stimulator of hepatic
macrophages. Cholinergic signals reportedly promote anti-
inﬂammatory responses of macrophages through the α7-
nicotinic receptor31,32. In addition, activation of muscarinic sig-
nals in the central nervous system has systemic anti-inﬂammatory
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properties, and these effects are reportedly elicited by efferent
vagal nerve-mediated nicotinic34, rather than muscarinic,
actions35 on peripheral immune cells. Meanwhile, since atropine
treatment blunted the carbachol-mediated (Fig. 6c) and PHx-
induced (Fig. 6d) upregulations of IL-6 in macrophages ex vivo
and in the remnant liver in vivo, respectively, muscarinic sig-
naling is involved in liver regeneration. Intriguingly, inﬂamma-
tory responses opposite those of hepatic macrophages to
cholinergic signals, depending on whether the signals are medi-
ated by muscarinic or nicotinic receptors, were recently repor-
ted33. Thus, responses of macrophages to vagal signals are likely
to differ depending on physiological or pathological situations.
Expression levels of muscarinic and nicotinic receptors on mac-
rophages might be altered according to various situations,
although further examinations are needed to elucidate the
molecular mechanism underlying the opposite responses of
macrophages to cholinergic stimulation.
In terms of the macrophage–hepatocyte link, IL-6 was revealed
to be a key mediator. Il-6 expression in the liver was rapidly and
markedly increased after PHx, and this increase was found to be
suppressed by vagotomy (Fig. 6a) and in hepatic macrophage-
depleted mice (Fig. 6b). IL-6 treatment activated the FoxM1
pathway in hepatocytes ex vivo (Fig. 7a), and activation of the
FoxM1 pathway after PHx was inhibited by antibody-mediated
blockade of hepatic IL-6 signaling in vivo (Fig. 7c). In addition,
PHx enhanced phosphorylation of hepatic STAT3 (Fig. 7b), a
downstream target of the IL-6 receptor, and this enhancement of
STAT3 phosphorylation was suppressed by anti-IL-6 antibody
treatment (Supplementary Fig. 5d). Consistently, hepatocyte-
speciﬁc STAT3 knockout mice reportedly show retardation of
liver regeneration after PHx36. Considering that STAT3 binds to
the Foxm1 gene promoter and that a STAT3 inhibitor was shown
to reduce Foxm1 expression in a leukemic cell line27, STAT3
phosphorylated by IL-6 signaling may transactivate Foxm1 gene
expression in regenerating hepatocytes.
Collectively, muscarinic signals from the vagal nerve may sti-
mulate IL-6 production by hepatic macrophages, thereby acti-
vating the hepatocyte FoxM1 pathway in a paracrine manner.
Thus, acute liver regenerative responses are achieved by a mul-
tistep mechanism comprised of neuronal, immune, and par-
enchymal cells. We recently reported that vagal signals directly
activate the FoxM1 pathway in pancreatic β-cells, thereby
enhancing compensatory proliferation10,11. Pancreatic islets are
richly innervated by vagal nerves11–13, and this anatomical fea-
ture may allow vagal signals to reach islet cells efﬁciently. In
contrast, it was reported that vagal nerves in the liver were
observed only around the portal region14. Therefore, to achieve
prompt regeneration of remnant hepatocytes, there must be a
distinct mechanism whereby neuronal signals are conveyed to
individual cells in the liver, which is a large organ. In this context,
taking advantage of resident macrophages as intermediaries,
regenerative signals from the vagal nerve can be ampliﬁed and
spread throughout the entire remnant liver by IL-6 secretion
(Fig. 8).
The ﬁndings obtained in the present study illustrate the novel
concept that a vagal signal–macrophage link promptly promotes
organ regeneration which is necessary especially after severe
organ injury. This concept may lead to better understanding of
both the organ regenerative process and the whole-body home-
ostasis-maintaining mechanisms. Organ regeneration is report-
edly regulated by neuronal signals in other tissues as well, such as
the limbs37,38 and pancreatic β-cells10,11. Macrophages also play
regulatory roles in the regeneration of several tissues other than
the liver, such as the spinal cord and the heart23. Thus, our results
raise the possibility of elucidating whether the vagal
signal–macrophage link is involved in the regenerations of other
organs/tissues and may be useful for developing novel strategies
for regenerative medicine.
Methods
Animals. Animal studies were conducted in accordance with the Tohoku Uni-
versity institutional guidelines. Ethical approval has been obtained from the
Institutional Animal Care and Use Committee of the Tohoku University Envir-
onmental & Safety Committee.
Male C57BL/6N mice were purchased from SLC Japan (Shizuoka, Japan).
Transgenic mice expressing a Cre recombinase transgene fused to mutated
estrogen receptor ligand-binding domains under the control of the mouse serum
albumin promoter/enhancer (SA-CreERT2)21 were gifts from Prof. Pierre
Chambon and Dr. Daniel Metzger (Institute of Genetics and Molecular and
Cellular Biology, Illkirch-Cedex, France). To obtain tamoxifen-inducible liver-
speciﬁc FoxM1 knockout (iFoxM1LKO) mice, we crossed SA-CreERT2 mice and
FoxM1ﬂox/ﬂox mice22. These mice have mixed backgrounds. At 8 weeks of age, SA-
CreERT2; FoxM1ﬂox/ﬂox mice and FoxM1ﬂox/ﬂox mice (as controls) were injected
intraperitoneally with 1 mg of tamoxifen (Sigma, St. Louis, MO, USA) dissolved in
corn oil (Sigma) every other day for 5 days, and were subjected to PHx 7 days after
the end of tamoxifen administration. All mice were housed individually in a
controlled environment (room temperature 25 °C) with a 12-h light–dark cycle,
and received standard chow and drinking water ad libitum. Animal studies were
conducted in accordance with Tohoku University institutional guidelines.
Surgical procedures. All operations were carried out on 8–10-week-old male
mice, anesthetized with an intraperitoneal injection containing a mixture
of medetomidine (0.3 mg/kg), midazolam (4 mg/kg), and butorphanol tartrate
(5 mg/kg). For HV, after incising the abdominal wall, the stomach was retracted to
expose the anterior vagal trunk and hepatic branch, and then only the hepatic
branch was transected with ﬁne forceps. Immediately after HV, 70% PHx was
performed. The left lateral and median lobes of the liver were securely ligated with
6-0 silk suture and resected39,40. For the sham operations, only the abdominal
incision was made, and the liver tissues and hepatic vagal branch were left intact.
At the completion of surgery, the abdominal muscles and skin were both sutured
layer by layer with 6-0 silk. In the experiments shown in Supplementary Fig. 1d,
PHx was performed 10 days after HV or sham operation for HV.
Recombinant adenovirus. Recombinant adenoviruses carrying the human Foxm1
gene (Ad-hFoxM1) and β-galactosidase gene (Ad-LacZ) were prepared41. Then,
1 × 108 plaque-forming units (PFU) per mouse of the Ad-hFoxM1 were injected
intravenously 1 day prior to PHx. The control mice were given 1 × 108 PFU per
mouse of the Ad-LacZ. In the experiments shown in l Fig. 5d, e, recombinant
adenoviruses were injected into mice immediately after control or clodronate
liposome administration.
In vivo carbachol treatment. Carbachol (Nacalai Tesque, Kyoto, Japan) was
dissolved in saline to 2 mmol/l, and mice were intraperitoneally administered 200
nmol carbachol (0.1 ml of 2 mmol/l solution). Livers were harvested 6 h after
carbachol administration.
In vivo atropine treatment. Atropine (Sigma) was dissolved in saline with ethanol
(10% v/v) to 625 mg/dl. Mice were intraperitoneally administered atropine, at 25
µg/g body weight, twice a day from 2 days before the surgical interventions until
kill.
Studies with Hepa1–6 cells. Murine hepatocyte cell line Hepa1–6 cells (CRL-
1830) were obtained from ATCC and maintained in Dulbecco’s modiﬁed Eagle
medium (DMEM) with 10% fetal bovine serum (FBS), 100 U/ml penicillin, and
100 µg/ml streptomycin (P/S) at 37 °C with 5% CO2 and 95% air. Hepa1–6 cells
were incubated with 100 µM carbachol (Nacalai Tesque) for 24 h, and then col-
lected for RNA extraction. Water was used as the vehicle.
Studies with peritoneal macrophages. Peritoneal macrophages were harvested
from lavage of 8-week-old male C57BL/6 N mice 4 days after intraperitoneal
injection with 4% thioglycollate (Sigma)42, plated onto 24-well plates with 1.0 × 105
cells per well and cultured in DMEM with 10% FBS and P/S. At 24 h after isolation,
the cells were incubated with 100 µM carbachol (Nacalai Tesque)43 and 100 µM
atropine (Sigma) for 4 h, and ﬁnally collected for RNA extraction. The carbachol
concentration was determined by examining dose-dependent effects of carbachol
on IL-6 expression in primary macrophages. The atropine concentration was
determined according to previously reported in vitro experiments11.
Macrophage depletion. To deplete hepatic macrophages, mice were intraper-
itoneally administered 140 µg/body clodronate or control liposomes (FormuMax
Scientiﬁc, Sunnyvale, CA, USA) 24 h prior to surgical interventions.
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Studies with primary hepatocytes. Primary hepatocytes were isolated by a col-
lagenase perfusion method44 from 10-week-old iFoxM1LKO and control male
mice. After making an abdominal incision, the portal vein was cannulated and the
inferior vena cava was cut, the liver was then perfused with Liver Perfusion
medium (Thermo Fisher Scientiﬁc, Waltham, MA, USA) at 5 ml/min for 9.5 min,
followed by perfusion with HEPES buffer containing 0.5 mg/ml collagenase
(Sigma) at 5 ml/min for an additional 9.5 min. The liver was excised and dis-
sociated in DMEM with 10% FBS and P/S, ﬁltered through a 70-µm nylon mesh,
and centrifuged at 50g for 5 min three times to clear the non-parenchymal fraction.
Then, fractions containing hepatocytes were suspended with 35% Percoll (GE
Healthcare, UK) solution and centrifuged at 60g for 10 min. The pellets were
washed and suspended with DMEM and plated onto 96-well plates with 2.5 × 104
cells per well. At 48 h after isolation, hepatocytes were incubated with 100 ng/ml
recombinant murine IL-6 (PEPROTECH, London, UK) for 6 h, and then collected
for RNA extraction. In experiments employing ex vivo carbachol treatment, to
avoid macrophage contamination, hepatocytes were incubated with 1 mM clo-
dronate liposomes for 1 h starting at 24 h after isolation. At 24 h after starting this
treatment with clodronate liposomes, the hepatocytes were stimulated with 100 µM
carbachol for 4 h. In STAT3 inhibition experiments, at 48 h after isolation, hepa-
tocytes were incubated with 100 µM cell-permeable STAT3 inhibitor peptide (EMD
Millipore, Billerica, MA, USA) for 1 h, and then stimulated with recombinant
murine IL-6 for 6 h.
RNA extraction and quantitative real-time PCR. Total RNA was extracted from
isolated macrophages, hepatocytes, and Hepa1–6 cells using an RNeasy Micro Kit
(Qiagen, Hilden, Germany), and from the liver using an RNeasy Mini Kit (Qiagen).
cDNA synthesis was performed with a QuantiTect Reverse Transcription Kit
(Qiagen) using 100 ng of RNA from cultured cells and 1 µg of total RNA from the
liver. Real-time PCR was performed using the Light Cycler Quick System 350S
(Roche Diagnostic, Mannheim, Germany)45. The relative amount of mRNA was
calculated with β-actin mRNA serving as the invariant control. The oligonucleotide
primers are presented in Supplementary Table 1.
Histological analysis. Excised liver specimens were ﬁxed in 10% formalin,
embedded in parafﬁn, and sectioned. Sections were stained with hematoxylin
and eosin. For bromodeoxyuridine (BrdU) in situ detection, mice were
injected intraperitoneally with 1 mg of BrdU (BD Bioscience, San Jose, CA, USA)
diluted to 10 mg/ml with phosphate-buffered saline 2 h before liver extraction. The
labeled cells were immunostained with anti-BrdU antibody (51-75512 L, BD
Bioscience). The number of BrdU-positive nuclei per 1000 hepatocytes per liver
specimen was counted. For detection of macrophages, liver sections were
stained with anti-F4/80 antibody (12-4801-80, Affymetrix eBioscience, Santa
Clara, CA, USA).
Immunoblotting. Liver samples were homogenized in lysis buffer containing 100
mM Tris, pH 8.5, 250 mM NaCl, 1 mM EDTA, 1 mM phenylmethylsulfonyl
ﬂuoride, aprotinin at 1:5000 dilution, and leupeptin at 1:5000 dilution46. Tissue
homogenates were centrifuged and the supernatants including tissue protein
extracts were boiled in Laemmli buffer containing 10 mM dithiothreitol, then
subjected to SDS-polyacrylamide gel electrophoresis. Separated proteins were
transferred to nitrocellulose membranes and blocked in Tris-buffered saline con-
taining 3% FBS. Immunoblot analyses were performed using antibodies to
phospho-STAT3 (Tyr705) (#9131, Cell Signaling Technology, Danvers, MA, USA),
total STAT3 (#4904, Cell Signaling Technology), phospho-STAT1 (Tyr701)
(#9167, Cell Signaling Technology), phospho-STAT5 (Tyr694) (#9314, Cell Sig-
naling Technology), FoxM1 (13147-1-AP, Proteintech, Rosemont, IL, USA), Cyclin
A2 (ab181591, Abcam, Cambridge, UK), Cdk1 (#28439, Cell Signaling Technol-
ogy), and PLK1 (#4535, Cell Signaling Technology) at 1:2000 dilution and actin
(A2066, Sigma) at 1:5000 dilution. Quantitative data were obtained employing a
ChemiDoc Touch Imaging System (Bio-Rad Laboratories, Hercules, CA, USA).
Uncropped membrane images are presented in Supplementary Fig. 6.
Plasma IL-6 measurement. Blood samples were collected from tail veins. Plasma
IL-6 concentrations were measured using a Mouse IL-6 ELISA kit (R&D Systems,
Minneapolis, MN, USA) according to the manufacturer’s instructions.
In vivo IL-6 neutralization. We administered 500 µg/body neutralizing antibodies
to IL-6 and control rat IgG (Bio X Cells, West Lebanon, NH, USA) intraper-
itoneally 1 hr before PHx.
Statistical analysis. All data are presented as means ± standard error. For
experiments in which data differences among three or four groups needed to be
assessed, we used one-way ANOVA followed by Bonferroni’s post hoc test. In
experiments in which data differences between two groups were assessed, results
were analyzed using the unpaired t test. Survival curves were estimated using the
Kaplan–Meier method and differences in survival among the groups were tested by
applying the log-rank test with Bonferroni correction. Differences were considered
to be signiﬁcant at p < 0.05. No statistical method was used to predetermine sample
size. Most sample sizes were chosen based on data from previous publications.
Statistical analyses were performed assuming a normal distribution in all
experiments.
Data availability
The data that support the ﬁndings of this study are available from the corre-
sponding author upon reasonable request. A Reporting Summary for this Article is
available as a Supplementary Information ﬁle.
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